#Healthcare
The indicative share price of SAR123 and SAR127 per share implies a market valuation of around SAR5.6bn at the top of the range
The healthcare operator is offering 13.3 million shares to investors – equivalent to 30 per cent of the company’s paid-up capital
The plan is live and can be purchased through Dubai Insurance Company, the OrangeCare website and Slice Of Wellness
From leveraging digital health technologies to fostering collaboration between the public and private sectors, the Cluster Head GCC at Novartis’ insights offer a roadmap for accelerating patient outcomes
Zahrat Al Rawdah, a wholly-owned subsidiary of Julphar, operates 173 pharmacy outlets across Saudi Arabia
By utilising patient data from various platforms, including Malaffi and Ifhas, the centres will create personalised health journeys tailored to individual needs
Here’s your guide to making the most of the Dubai Fitness Challenge to jumpstart your wellness journey
The CEO of NeuroPro and Virtually Live shares insights on how VR and AI are rapidly transforming healthcare, particularly in rehabilitation, mental health therapy, and patient education
The acquisition marks a significant step forward for Abu Dhabi state investor in the life sciences sector, positioning the UAE as a key player in the global market
Sixty-five percent of respondents reported experiencing mental health challenges in the past year, yet a surprising 82 per cent rated their overall wellbeing as positive
The budget maintains a balance between income and spending, with both revenues and expenditures approved at $19.6bn (Dhs71.5bn)
Artificial intelligence is not just enhancing healthcare – it’s redefining it, offering the promise of a future where medicine is more personalised, proactive and powerful than ever before
The platform has collaborations with over 1,500 hospitals and wellness centres across the US, UK, Germany, UAE, Saudi Arabia, Thailand, India, Singapore and Egypt
M42 is set to officially commence full-scale operations at the military hospital in early 2025
Through strategic actions, Saudi Arabia and UAE could capture over 60 per cent of MENA’s $1.2bn genomics market by 2027
The deal, which is expected to close in Q4 2024, includes UCB’s neurology portfolio (Keppra, Vimpat, Neupro) and allergy medicines (Zyrtec, Xyzal)
We profile some of the most iconic Indian business titans based in the Gulf, highlighting their journeys and achievements
Vote for the most deserving individuals and businesses for the upcoming awards
Dallah will issue 3.89 million shares to Ayyan as part of the capital increase, valued at SAR660m
Dubai’s health tourism sector generated indirect revenues of Dhs2.3bn in 2023, providing a significant boost to the emirate’s GDP
Elia G Nuqul, director of Wellness at FHH, delves into the vision for its future, the role of technology in wellness and the key trends shaping the industry
Burjeel Holdings remains focused on expanding its oncology services, which are expected to play a key role in boosting future revenue streams
RPM CEO Dr Rohil Raghavan shares how the medical services provider continues to enhance the quality of healthcare services in the UAE, Saudi Arabia and beyond
Part of the Zayed Humanitarian Legacy Initiative, the ambitious project will see a financial investment of nearly $150m (Dhs550m) over the next decade
We are now accepting nominations for the 12th edition of the Gulf Business Awards 2024
The sale will advance the healthcare firm’s focus on specialised services previously offered at Abu Dhabi Stem Cells Centre and Yas Clinic at Sheikh Shakbout Medical City
The government-backed entities seek to leverage the emirate’s strategic location, lucrative investment opportunities and advanced logistics capabilities
Located in Al Jasra, the facility will offer long-term care for patients with complex medical needs
The Afiyah Fund raised the money from a group of Saudi Arabian, GCC and European investors, led by Jada Fund of Funds
The pricing of SAR57.5 per share implies a market valuation of around SAR13.3bn at listing